Sun Financial’s AbbVie ABBV Stock Holding History

Sun Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,891	Closed	-$399K	–	162
2026 Q1	$399K	Sell	1,891 -38	-2%	-$8.43K	0.2%	99
2025 Q4	$441K	Buy	+1,929	New	+$439K	0.25%	94

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sun Financial's ABBV Position: Q2 2026 in Review

Sun Financial sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,891 shares — an estimated $399K sold.

Sun Financial first reported a position in ABBV in Q4 2025 and held it in 2 quarters. The position peaked at $441K in Q4 2025. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sun Financial reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Sun Financial sold 1,891 AbbVie shares in Q2 2026, an estimated $399K.
Sun Financial first reported a position in AbbVie in Q4 2025 and held it in 2 quarters.
Sun Financial's AbbVie position peaked at $441K in Q4 2025.
4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sun Financial's 13F filing for Q2 2026, filed 12 Aug 2026.